Preventative Maintenance Labs on Steroids and TRT

Member Access Required

Already a member? Sign In

Timeline

00:03

Preventive monitoring is introduced as a way to reduce hidden cardiac and metabolic risk. The segment stresses CBC and metabolic panels as basic safety tools for androgen users.

02:35

Cardiac screening is emphasized using calcium scoring, EKGs, and echocardiograms for early detection. The message is that prevention beats reacting after plaque or heart enlargement appears.

Video Summary

Preventive maintenance is framed as essential for people using steroids or testosterone therapy. The emphasis is that most serious outcomes involve the heart and vascular system. Routine bloodwork is recommended so trends are noticed before symptoms become severe. A complete blood count is discussed to track hemoglobin and hematocrit changes. A comprehensive metabolic panel is emphasized for liver enzymes and kidney function signals. The goal is to interpret results in context instead of reacting to single flagged values. Working with a qualified clinician is presented as the best way to individualize monitoring.

The video highlights red blood cell elevation and urges careful evaluation of the cause. Conditions like polycythemia and hereditary hemochromatosis are mentioned as important differentials. Repeated self-phlebotomy is discouraged unless a clear medical indication exists. Risk assessment expands beyond blood counts to plaque, blood pressure, lipids, and glucose. A coronary artery calcium score is described as a low radiation CT option for many men. The point is to identify atherosclerosis early rather than waiting for an emergency event. Older lifters with risk factors are encouraged to think like prevention-focused cardiology patients.

Baseline studies are discussed, including an EKG and an echocardiogram for heart structure. An enlarged heart or early diastolic dysfunction is described as detectable before major failure. The talk also mentions evidence-based medications and metabolic tools used in modern practice. Examples include statins for lipids and metformin for insulin resistance when appropriate clinically. Nonsteroidal anti-inflammatory drugs are noted as common medicines with meaningful tradeoffs. The conclusion is to keep doses reasonable, track vitals, and repeat key studies over time. Staying healthy is framed as a long game built on monitoring, prevention, and honest follow-through.

Drug Callouts

Testosterone

Testosterone is an androgen hormone medication used to treat clinically confirmed male hypogonadism. It is discussed as a therapy that may accelerate cardiovascular risk in susceptible men.

Metformin

Metformin is an oral medication that improves insulin sensitivity and lowers hepatic glucose output. It is mentioned as a modern tool sometimes used beyond overt diabetes in selected patients.

Statins

Statins are cholesterol-lowering drugs that reduce LDL and lower atherosclerotic cardiovascular event risk. The transcript references their use within prevention protocols for higher-risk men.

Aspirin

Aspirin is an antiplatelet medication that reduces platelet aggregation and clot formation in arteries. It is mentioned while discussing prevention, while noting that strong outcome data is limited.

Nonsteroidal anti-inflammatory drugs (NSAIDs)

NSAIDs are pain and inflammation medications that can affect blood pressure, kidneys, and gastrointestinal safety. They are mentioned as common medicines requiring awareness of tradeoffs and monitoring.

Condition Callouts

Coronary artery disease

Coronary artery disease is narrowing of coronary arteries from plaque that reduces heart blood flow. It is discussed as a major cause of death that androgen use may worsen indirectly.

Atherosclerosis

Atherosclerosis is the gradual buildup of lipid-rich plaque within arterial walls over time. Calcium scoring is presented as a way to detect plaque before symptoms occur.

Androgen-induced erythrocytosis

Androgen-induced erythrocytosis is a rise in red blood cell mass associated with exogenous androgen exposure. The transcript emphasizes monitoring hematocrit and evaluating contributing factors carefully.

Polycythemia

Polycythemia is an abnormally high red blood cell concentration that can increase blood viscosity. It is raised as a possible explanation for elevated hematocrit beyond androgen effects alone.

Hereditary hemochromatosis

Hereditary hemochromatosis is a genetic disorder causing excess iron absorption and iron overload. It is mentioned as a reason some men may need targeted testing and specialist input.

Diabetes mellitus

Diabetes mellitus is chronic hyperglycemia that increases vascular and kidney complication risk. It is discussed alongside glucose testing as part of routine preventive lab assessment.

Prediabetes

Prediabetes is impaired glucose regulation that raises future diabetes and cardiovascular risk. The transcript references screening for early metabolic disease before complications develop.

Left ventricular hypertrophy

Left ventricular hypertrophy is thickening of the heart muscle often linked to hypertension or chronic strain. Echocardiography is mentioned as a study that can identify this structural change.

Diastolic dysfunction

Diastolic dysfunction is impaired relaxation of the heart that can precede symptomatic heart failure. It is mentioned as an early finding that echocardiograms can detect during screening.

Key Takeaways

Routine CBC and metabolic panels help detect liver, kidney, and red cell changes early.
Elevated hematocrit should trigger evaluation, not automatic repeated phlebotomy decisions.
Calcium scoring and echocardiography can identify plaque and heart enlargement before symptoms.
Risk assessment should include blood pressure, lipids, and glucose rather than one lab value.
Prevention works best when monitoring is individualized with a qualified medical clinician.